Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
104866824 | 10486682 | 4 | F | 20160901 | 20141001 | 20160907 | EXP | US-JNJFOC-20140926926 | JANSSEN | 0.00 | C | M | Y | 0.00000 | 20160907 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
104866824 | 10486682 | 1 | SS | RISPERDAL | RISPERIDONE | 1 | Oral | U | U | 0 | TABLETS | ||||||||
104866824 | 10486682 | 2 | SS | RISPERDAL | RISPERIDONE | 1 | Oral | U | U | 0 | TABLETS | ||||||||
104866824 | 10486682 | 3 | PS | RISPERDAL | RISPERIDONE | 1 | Oral | U | U | 20272 | TABLETS | ||||||||
104866824 | 10486682 | 4 | SS | RISPERIDONE. | RISPERIDONE | 1 | Oral | N | 0 | TABLETS | |||||||||
104866824 | 10486682 | 5 | SS | RISPERIDONE. | RISPERIDONE | 1 | Oral | N | 0 | TABLETS | |||||||||
104866824 | 10486682 | 6 | SS | RISPERIDONE. | RISPERIDONE | 1 | Oral | N | 0 | TABLETS |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
104866824 | 10486682 | 1 | Impulsive behaviour |
104866824 | 10486682 | 2 | Attention deficit/hyperactivity disorder |
104866824 | 10486682 | 3 | Autism spectrum disorder |
104866824 | 10486682 | 4 | Impulsive behaviour |
104866824 | 10486682 | 5 | Attention deficit/hyperactivity disorder |
104866824 | 10486682 | 6 | Autism spectrum disorder |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
104866824 | 10486682 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
104866824 | 10486682 | Galactorrhoea | |
104866824 | 10486682 | Gynaecomastia | |
104866824 | 10486682 | Hyperprolactinaemia | |
104866824 | 10486682 | Obesity | |
104866824 | 10486682 | Product use issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |